Intra-Cellular Therapies
ITCI
#1310
Rank
NZ$24.01 B
Marketcap
$225.82
Share price
0.00%
Change (1 day)
110.12%
Change (1 year)

EPS for Intra-Cellular Therapies (ITCI)

EPS in 2023 (TTM): -$2.60

According to Intra-Cellular Therapies's latest financial reports the company's current EPS (TTM) is -$2.77. In 2022 the company made an earnings per share (EPS) of -$4.67 an increase over its 2021 EPS that were of -$6.01.

EPS history for Intra-Cellular Therapies from 2014 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$2.60-44.33%
2022-$4.67-22.29%
2021-$6.018.02%
2020-$5.5720.9%
2019-$4.60-5.63%
2018-$4.8833.96%
2017-$3.64-21.19%
2016-$4.62-7.56%
2015-$5.00174.53%
2014-$1.82

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$0.43-84.47%๐Ÿ‡บ๐Ÿ‡ธ USA
-$17.18 521.12%๐Ÿ‡บ๐Ÿ‡ธ USA
-$3.68 32.92%๐Ÿ‡บ๐Ÿ‡ธ USA